New hope for mesothelioma patients: experimental drug targets tumor growth
NCT ID NCT06840834
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This study tests a drug called ivonescimab in 38 people with pleural mesothelioma whose cancer returned after standard treatments. The drug aims to slow or stop tumor growth by blocking blood vessel formation and reactivating the immune system. Participants receive the drug every 3 weeks for up to 2 years, and researchers will measure how many patients have their disease controlled at 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLEURAL MESOTHELIOMAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Besançon - CHU
RECRUITINGBesançon, France
-
Bordeaux - CHU
RECRUITINGPessac, France
-
Brest - CHU
RECRUITINGBrest, France
-
Caen - CHU
RECRUITINGCaen, France
-
Clermont-Ferrand - Centre Jean Perrin
RECRUITINGClermont-Ferrand, France
-
Créteil - CHI
RECRUITINGCréteil, France
-
Grenoble - CHU
RECRUITINGGrenoble, France
-
Le Mans - CHG
RECRUITINGLe Mans, France
-
Lille - CHU
RECRUITINGLille, France
-
Lyon - HCL
RECRUITINGPierre-Bénite, France
-
Marseille - APHM
RECRUITINGMarseille, France
-
Metz - Hôpital Robert Schuman
RECRUITINGVantoux, France
-
Montpellier - CHU
RECRUITINGMontpellier, France
-
Mulhouse - GHRMSA
RECRUITINGMulhouse, France
-
Nantes - Hôpital Laennec
RECRUITINGNantes, France
-
Paris - Bichat
RECRUITINGParis, France
-
Strasbourg - Nouvel Hôpital Civil
RECRUITINGStrasbourg, France
-
Toulon - CHI
RECRUITINGToulon, France
-
Toulouse - CHU
RECRUITINGToulouse, France
-
Tours - CHU
RECRUITINGTours, France
Conditions
Explore the condition pages connected to this study.